Skip to main content
Log in

The Future of Cancer Management: Translating the Genome, Transcriptome, and Proteome

  • Educational Review
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Abstract: Predicting who will develop cancer and how the cancer will behave and respond to therapy after diagnosis are some of the potential benefits of the ongoing genetic revolution that can be envisioned within the next decade. Translational applications of genomic-based research efforts may actually precede the development of effective therapeutic agents that can exploit the vast amounts of data derived from these efforts. In the future, understanding the wealth of information generated by high-throughput molecular efforts and how it can be applied to clinical problems will likely be critical to the surgeon who guides the multidisciplinary care of the cancer patient. This review will discuss the advances in our understanding of the human genome (DNA), its derived transcriptome (RNA), and its translated proteome (proteins) and will focus on the translation of this information into routine clinical practice. In particular, we will focus on the potential for clinical application of microarray-based gene-expression profiling to the diagnosis, prognosis, and therapy of malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Lewin R. Proposal to sequence the human genome stirs debate. Science 1986; 232: 1598–600.

    Google Scholar 

  2. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860–921.

    Article  PubMed  Google Scholar 

  3. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001; 291: 1304–51.

    Article  CAS  PubMed  Google Scholar 

  4. Saha S, Sparks AB, Rago C, et al. Using the transcriptome to annotate the genome. Nat Biotechnol 2002; 20: 508–12.

    Google Scholar 

  5. Adams MD, Celniker SE, Holt RA, et al. The genome sequence of Drosophila melanogaster . Science 2000; 287: 2185–95.

    Article  PubMed  Google Scholar 

  6. Genome sequence of the nematode C. elegans: a platform for investigating biology. The C. elegans Sequencing Consortium. Science 1998;282:2012–8.

    Google Scholar 

  7. Analysis of the genome sequence of the flowering plant Arabidop-sis thaliana Nature Science 2000;408:796 – 815.

  8. Webb T. SNPs: can genetic variants control cancer susceptibility? J Natl Cancer Inst 2002; 94: 476–8.

    Google Scholar 

  9. Relling MV, Dervieux T. Pharmacogenetics and cancer therapy. Nat Rev Cancer 2001; 1: 99–108.

    Google Scholar 

  10. Srinivas PR, Kramer BS, Srivastava S. Trends in biomarker research for cancer detection. Lancet Oncol 2001; 2: 698–704.

    Google Scholar 

  11. Brock GJ, Huang TH, Chen CM, Johnson KJ. A novel technique for the identification of CpG islands exhibiting altered methylation patterns (ICEAMP). Nucleic Acids Res 2001; 29: E123.

    Google Scholar 

  12. Yan PS, Wei SH, Huang TH. Differential methylation hybridization using CpG island arrays. Methods Mol Biol 2002; 200: 87–100.

    Google Scholar 

  13. Suzuki H, Gabrielson E, Chen W, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002; 31: 141–9.

    Google Scholar 

  14. Su AI, Cooke MP, Ching KA, et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A 2002; 99: 4465–70.

    Google Scholar 

  15. Quackenbush J. Computational analysis of microarray data. Nat Rev Genet 2001; 2: 418–27.

    Google Scholar 

  16. Ideker T, Galitski T, Hood L. A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet 2001; 2: 343–72.

    Google Scholar 

  17. Davidson EH, Rast JP, Oliveri P, et al. A genomic regulatory network for development. Science 2002; 295: 1669–78.

    Article  CAS  PubMed  Google Scholar 

  18. Graham TA, Weaver C, Mao F, et al. Crystal structure of a beta-catenin/Tcf complex. Cell 2000; 103: 885–96.

    Google Scholar 

  19. Sperling K. From proteomics to genomics. Electrophoresis 2001; 22: 2835–7.

    Google Scholar 

  20. Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik 1975; 26: 231–43.

    Google Scholar 

  21. O’Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975; 250: 4007–21.

    Google Scholar 

  22. Scheele GA. Two-dimensional gel analysis of soluble proteins. Characterization of guinea pig exocrine pancreatic proteins. J Biol Chem 1975; 250: 5375–85.

    Google Scholar 

  23. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997; 18: 533–7.

    Google Scholar 

  24. Lee KH. Proteomics: a technology-driven and technology-limited discovery science. Trends Biotechnol 2001; 19: 217–22.

    Article  CAS  PubMed  Google Scholar 

  25. Agrawal D, Chen T, Irby R, et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 2002; 94: 513–21.

    Google Scholar 

  26. Giordano TJ, Shedden KA, Schwartz DR, et al. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol 2001; 159: 1231–8.

    Google Scholar 

  27. Ramaswamy S, Tamayo P, Rifkin R, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 2001; 98: 15149–54.

    Article  CAS  PubMed  Google Scholar 

  28. Alizadeh AA, Ross DT, Perou CM, van de Rijn M. Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 2001; 195: 41–52.

    Google Scholar 

  29. Su AI, Welsh JB, Sapinoso LM, et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 2001; 61: 7388–93.

    Google Scholar 

  30. Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 2001; 98: 13790–5.

    Article  CAS  PubMed  Google Scholar 

  31. Shipp MA, Ross KN, Tamayo P, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002; 8: 68–74.

    Google Scholar 

  32. Takahashi M, Rhodes DR, Furge KA, et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci U S A 2001; 98: 9754–9.

    Google Scholar 

  33. West M, Blanchette C, Dressman H, et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A 2001; 98: 11462–7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Timothy J. Yeatman MD, FACS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yeatman, T.J. The Future of Cancer Management: Translating the Genome, Transcriptome, and Proteome. Ann Surg Oncol 10, 7–14 (2003). https://doi.org/10.1245/ASO.2003.05.031

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.05.031

Key Words

Navigation